DMS114 cells with resistance to nintedanib (a kinase inhibitor used to block cancer growth) (DMS114/NIN) portrayed an amplified expression of EDN1 and EDNRA, encoding ET-1 and ETAR, respectively. Here, EDNRA is linked to cancer.